A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study - Angiolillo, DJ; Capranzano, P; Goto, S (Eur Heart J, 2008)
et al.